Afirma GSC Shows Improved Results in Evaluating Indeterminate Thyroid Nodules, Especially Hürthle-Cell Lesions

Clinical ThyroidologyVol. 31, No. 5 Thyroid NodulesAfirma GSC Shows Improved Results in Evaluating Indeterminate Thyroid Nodules, Especially Hürthle-Cell LesionsStephanie A. FishStephanie A. FishDepartment of Endocrinology, Memorial Sloan Kettering Cancer Center, New York, New York, U.S.A.Search for more papers by this authorPublished Online:8 May 2019https://doi.org/10.1089/ct.2019;31.198-200AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 31Issue 5May 2019 InformationCopyright 2019 American Thyroid Association, Inc.To cite this article:Stephanie A. Fish.Afirma GSC Shows Improved Results in Evaluating Indeterminate Thyroid Nodules, Especially Hürthle-Cell Lesions.Clinical Thyroidology.May 2019.198-200.http://doi.org/10.1089/ct.2019;31.198-200Published in Volume: 31 Issue 5: May 8, 2019PDF download